Antonin Weckel

Antonin joined Sofinnova Partners as an Analyst with the Capital Strategy in April 2024.

Before joining Sofinnova Partners, he was a postdoctoral fellow in dermatology and immunology at the University of California San Francisco (UCSF), where he focused on how tolerance to skin commensals is established.

“I am continuously excited by emerging technologies and innovative solutions from researchers across the world, and how they can be harnessed into therapeutic solutions,” Antonin said. “I consider good science to be the foundation for any successful therapeutic opportunity, a belief that is deeply embedded in Sofinnova’s approach.”

Throughout his career in academic research, Antonin’s work has been published in journals such as: Immunity, JCI and PNAS. He takes great pleasure in collaborating with others, which has led him to co-author more than fourteen papers.

Antonin did most of his studies in Paris. He holds a Bachelor of Science degree from the Ecole Normale Supérieure, a Master’s degree from Paris Descartes University, and conducted his PhD at the Cochin Institute.